Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 1986 Sep 15;238(3):863–869. doi: 10.1042/bj2380863

Abnormal regulation of insulin secretion in the genetically obese (ob/ob) mouse.

M Black, H M Heick, N Bégin-Heick
PMCID: PMC1147215  PMID: 3026362

Abstract

To determine whether the abnormal insulin-secretory activity encountered in obese mice is due to an anomaly in the production of cyclic AMP, islets of lean and obese mice were incubated with forskolin under various conditions. Our data show that, in addition to the well-known quantitative differences in insulin-secretory activity between islets of lean and obese mice, there are important qualitative differences. The islets of obese mice accumulated less cyclic AMP than did those of lean mice in response to given doses of forskolin, yet their insulin secretion was enhanced to much higher values. In the islets of obese mice, but not in those of lean mice, the stimulatory effect of forskolin on insulin secretion was evident even at non-stimulatory concentrations of glucose or in Ca2+-deprived incubation media, showing that the islet of the obese mouse is less dependent on a primary stimulus (glucose) and on the provision of normal concentrations of Ca2+ in the bathing medium than is the islet of the lean mouse.

Full text

PDF
863

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ahrén B., Lundquist I. Modulation of basal insulin secretion in the obese, hyperglycemic mouse. Metabolism. 1982 Feb;31(2):172–179. doi: 10.1016/0026-0495(82)90131-7. [DOI] [PubMed] [Google Scholar]
  2. Ashby J. P., Shirling D. Evidence for priming and inhibitory effects of glucose on insulin secretion from isolated islets of Langerhans. Diabetologia. 1980 May;18(5):417–421. doi: 10.1007/BF00276824. [DOI] [PubMed] [Google Scholar]
  3. Ashby J. P., Shirling D. The priming effect of glucose on insulin secretion from isolated islets of Langerhans. Diabetologia. 1981 Sep;21(3):230–234. doi: 10.1007/BF00252659. [DOI] [PubMed] [Google Scholar]
  4. Brisson G. R., Malaisse-Lagae F., Malaisse W. J. The stimulus-secretion coupling of glucose-induced insulin release. VII. A proposed site of action for adenosine-3',5'-cyclic monophosphate. J Clin Invest. 1972 Feb;51(2):232–241. doi: 10.1172/JCI106808. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bégin-Heick N. Absence of the inhibitory effect of guanine nucleotides on adenylate cyclase activity in white adipocyte membranes of the ob/ob mouse. Effect of the ob gene. J Biol Chem. 1985 May 25;260(10):6187–6193. [PubMed] [Google Scholar]
  6. Cerasi E., Luft R. The effect of an adenosine--3'5'--monophosphate diesterase inhibitor (aminophylline) on the insulin response to glucose infusion in prediabetic and diabetic subjects. Horm Metab Res. 1969 Jul;1(4):162–168. doi: 10.1055/s-0028-1095148. [DOI] [PubMed] [Google Scholar]
  7. Dalpé-Scott M., Heick H. M., Bégin-Heick N. An improved double antibody radioimmunoassay for the determination of insulin in serum, plasma, and tissue incubation media. Can J Biochem. 1982;60(10):962–966. doi: 10.1139/o82-123. [DOI] [PubMed] [Google Scholar]
  8. Dalpé-Scott M., Heick H. M., Bégin-Heick N. Insulin secretion in the obese (ob/ob) mouse. The effect of oxytetracycline on insulin release. Diabetes. 1983 Oct;32(10):932–937. doi: 10.2337/diab.32.10.932. [DOI] [PubMed] [Google Scholar]
  9. Dubuc P. U. Effects of limited food intake on the obese-hyperglycemic syndrome. Am J Physiol. 1976 Jun;230(6):1474–1479. doi: 10.1152/ajplegacy.1976.230.6.1474. [DOI] [PubMed] [Google Scholar]
  10. Dunbar J. C., Walsh M. F. Glucagon and insulin secretion by islets of lean and obese (ob/ob) mice. Horm Metab Res. 1980 Jan;12(1):39–40. doi: 10.1055/s-2007-996193. [DOI] [PubMed] [Google Scholar]
  11. Eddlestone G. T., Oldham S. B., Lipson L. G., Premdas F. H., Beigelman P. M. Electrical activity, cAMP concentration, and insulin release in mouse islets of Langerhans. Am J Physiol. 1985 Jan;248(1 Pt 1):C145–C153. doi: 10.1152/ajpcell.1985.248.1.C145. [DOI] [PubMed] [Google Scholar]
  12. Hellman B., Idahl L. A., Lernmark A., Täljedal I. B. The pancreatic beta-cell recognition of insulin secretagogues: does cyclic AMP mediate the effect of glucose? Proc Natl Acad Sci U S A. 1974 Sep;71(9):3405–3409. doi: 10.1073/pnas.71.9.3405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Henquin J. C., Meissner H. P. The ionic, electrical, and secretory effects of endogenous cyclic adenosine monophosphate in mouse pancreatic B cells: studies with forskolin. Endocrinology. 1984 Sep;115(3):1125–1134. doi: 10.1210/endo-115-3-1125. [DOI] [PubMed] [Google Scholar]
  14. Henquin J. C., de Miguel R., Garrino M. G., Hermans M., Nenquin M. Nutrient insulin secretagogues decrease 45Ca2+ efflux from islet cells by a mechanism other than the inhibition of the Na+-Ca2+ countertransport. FEBS Lett. 1985 Jul 22;187(1):177–181. doi: 10.1016/0014-5793(85)81237-0. [DOI] [PubMed] [Google Scholar]
  15. Herberg L., Coleman D. L. Laboratory animals exhibiting obesity and diabetes syndromes. Metabolism. 1977 Jan;26(1):59–99. doi: 10.1016/0026-0495(77)90128-7. [DOI] [PubMed] [Google Scholar]
  16. Lavine R. L., Voyles N., Perrino P. V., Recant L. Functional abnormalities of islets of Langerhans of obese hyperglycemic mouse. Am J Physiol. 1977 Aug;233(2):E86–E90. doi: 10.1152/ajpendo.1977.233.2.E86. [DOI] [PubMed] [Google Scholar]
  17. Lenzen S. Insulin secretion by isolated perfused rat and mouse pancreas. Am J Physiol. 1979 Apr;236(4):E391–E400. doi: 10.1152/ajpendo.1979.236.4.E391. [DOI] [PubMed] [Google Scholar]
  18. Malaisse W. J., Garcia-Morales P., Dufrane S. P., Sener A., Valverde I. Forskolin-induced activation of adenylate cyclase, cyclic adenosine monophosphate production and insulin release in rat pancreatic islets. Endocrinology. 1984 Nov;115(5):2015–2020. doi: 10.1210/endo-115-5-2015. [DOI] [PubMed] [Google Scholar]
  19. Maldonato A., Renold A. E., Sharp G. W., Cerasi E. Glucose-induced proinsulin biosynthesis. Role of islet cyclic AMP. Diabetes. 1977 Jun;26(6):538–545. doi: 10.2337/diab.26.6.538. [DOI] [PubMed] [Google Scholar]
  20. Matthews E. K. Calcium translocation and control mechanisms for endocrine secretion. Symp Soc Exp Biol. 1979;33:225–249. [PubMed] [Google Scholar]
  21. Rabinovitch A., Cerasi E., Sharp G. W. Adenosine 3',5'-monophosphate-dependent and -independent inhibitory effects of epinephrine on insulin release in rat pancreatic islets. Endocrinology. 1978 Jun;102(6):1733–1740. doi: 10.1210/endo-102-6-1733. [DOI] [PubMed] [Google Scholar]
  22. Rosario L. M., Atwater I., Rojas E. Membrane potential measurements in islets of Langerhans from ob/ob obese mice suggest an alteration in [Ca2+]i-activated K+ permeability. Q J Exp Physiol. 1985 Jan;70(1):137–150. doi: 10.1113/expphysiol.1985.sp002885. [DOI] [PubMed] [Google Scholar]
  23. Rosario L. M. Differential effects of the K+ channel blockers apamin and quinine on glucose-induced electrical activity in pancreatic beta-cells from a strain of ob/ob (obese) mice. FEBS Lett. 1985 Sep 2;188(2):302–306. doi: 10.1016/0014-5793(85)80391-4. [DOI] [PubMed] [Google Scholar]
  24. Seamon K., Daly J. W. Activation of adenylate cyclase by the diterpene forskolin does not require the guanine nucleotide regulatory protein. J Biol Chem. 1981 Oct 10;256(19):9799–9801. [PubMed] [Google Scholar]
  25. Sharp G. W. The adenylate cyclase-cyclic AMP system in islets of Langerhans and its role in the control of insulin release. Diabetologia. 1979 May;16(5):287–296. doi: 10.1007/BF01223617. [DOI] [PubMed] [Google Scholar]
  26. Siegel E. G., Wollheim C. B., Kikuchi M., Renold A. E., Sharp G. W. Dependency of cyclic AMP-induced insulin release on intra- and extracellular calcium in rat islets of Langerhans. J Clin Invest. 1980 Feb;65(2):233–241. doi: 10.1172/JCI109665. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Somers G., Devis G., Van Obberghen E., Malaisse W. J. Calcium antagonists and islet function. II. Interaction of theophylline and verapamil. Endocrinology. 1976 Jul;99(1):114–124. doi: 10.1210/endo-99-1-114. [DOI] [PubMed] [Google Scholar]
  28. Thams P., Capito K., Hedeskov C. J. Differential effects of Ca2+-calmodulin on adenylate cyclase activity cyclase activity in mouse and rat pancreatic islets. Biochem J. 1982 Jul 15;206(1):97–102. doi: 10.1042/bj2060097. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Ullrich S., Wollheim C. B. Islet cyclic AMP levels are not lowered during alpha 2-adrenergic inhibition of insulin release. J Biol Chem. 1984 Apr 10;259(7):4111–4115. [PubMed] [Google Scholar]
  30. Wiedenkeller D. E., Sharp G. W. Effects of forskolin on insulin release and cyclic AMP content in rat pancreatic islets. Endocrinology. 1983 Dec;113(6):2311–2313. doi: 10.1210/endo-113-6-2311. [DOI] [PubMed] [Google Scholar]
  31. Wollheim C. B., Sharp G. W. Regulation of insulin release by calcium. Physiol Rev. 1981 Oct;61(4):914–973. doi: 10.1152/physrev.1981.61.4.914. [DOI] [PubMed] [Google Scholar]
  32. Wollheim C. B., Siegel E. G., Kikuchi M., Renold A. E., Sharp G. W. The role of extracellular Ca++ and islet calcium stores in the regulation of biphasic insulin release. Horm Metab Res Suppl. 1980;Suppl 10:108–115. [PubMed] [Google Scholar]
  33. Zawalich W., Brown C., Rasmussen H. Insulin secretion: combined effects of phorbol ester and A23187. Biochem Biophys Res Commun. 1983 Dec 16;117(2):448–455. doi: 10.1016/0006-291x(83)91221-4. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES